东阳光

湖北省

Years

周雪娇

查看

基本信息

企业名称

东阳光

企业地址

湖北省宜都市滨江路38号

成立日期

2002

企业规模（人）

500以上

年销售额（USD）

100,000,000至249,999,999

企业简介

HEC Pharm Group is an emerging pharmaceutical company specialized in development, production and marketing of quality and affordable generics, APIs and intermediates for worldwide markets. HEC also provides services for contract R&D and manufacturing. All manufacture facilities of HEC have been GMP certified by both U.S FDA and European authorities. HEC can provide the value added formulations based on its strong R&D capability. HEC has Zidovudine tablets approved by U.S FDA and Azithromycin tablets approved by German BfArM and WHO. The company also offers qualified APIs with DMF and CEP, such as Telaprevir, Atorvastatin, Ticagrelor, Clopidogrel, Azilsartan, etc.

主要竞争优势

国际认证/标准,经验丰富的研发人员,生产能力,接受小额订单,良好的信誉

邮政编码

443399

贸易信息

业务类型

制造商,出口商

主要销售市场

北美洲,西欧,亚洲

主营产品类别

中间体,原料药

产品外销比重

产品内销比重

主要客户名称

参展信息

主营产品

Azithromycin Dihydrate(117772-70-0);Azithromycin Monohydrate(121470-24-4);Clarithromycin(81103-11-9);Erythromycin Base(114-07-8);Lincomycin Hydro(7179-49-9)chloride;Rosuvastatin Ca(147098-20-2);Sitagliptin Phosphate Monohydrate(654671-77-9);Aripiprazole(129722-12-9);Rivaroxaban(366789-02-8);Apixaban(503612-47-3);Ticagrelor(274693-27-5);Alogliptin Benzoate(850649-62-6);Linagliptin(668270-12-0);Fingolimod Hydrochloride(162359-56-0);Tadalafil(171596-29-5);Prasugrel Hydrochloride(389574-19-0)

参展展会

第二十三届世界制药原料中国展

展会时间

2025-03-06至2025-07-31

展位号

E1H18

展品分类

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Excipients & Drug Formulation;Finished Dosage;Bio Products;Veterinary Drug & Feed Additives

参展信息